Scrip Regulatory Affairs
Hong Kong prepares for statutory medtech regulations, consults on new elements
26 August 2010
Vibha Sharma
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- EU Commission proposes clinical evidence requirements for all IVDs except lowest-risk
- Malaysia consults on grouping of devices to facilitate registration process
- Canada consults on plans to schedule device company inspections based on risk
- GHTF successor IMDRF to expand membership; shortlists work priorities at inaugural meeting
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
